The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuneyoshi, N.
Right arrow Articles by Kimoto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuneyoshi, N.
Right arrow Articles by Kimoto, M.
The Journal of Immunology, 2005, 174: 340-344.
Copyright © 2005 by The American Association of Immunologists

The Functional and Structural Properties of MD-2 Required for Lipopolysaccharide Binding Are Absent in MD-11

Naoko Tsuneyoshi*, Kenji Fukudome2,*, Jun Kohara*, Rika Tomimasu*, Jean-Francois Gauchat{dagger}, Hiroshi Nakatake{ddagger} and Masao Kimoto*

* Department of Immunology, Saga Medical School, Saga, Japan; {dagger} Department of Pharmacology, University of Montreal, Montreal, Quebec, Canada; and {ddagger} First Research Department, The Chemo-Sero-Therapeutic Research Institute, Kumamoto, Japan

MD-1 and MD-2 are secretory glycoproteins that exist on the cell surface in complexes with transmembrane proteins. MD-1 is anchored by radioprotective 105 (RP105), and MD-2 is associated with TLR4. In vivo studies revealed that MD-1 and MD-2 have roles in responses to LPS. Although the direct binding function of MD-2 to LPS has been observed, the physiological function of MD-1 remains unknown. In this study, we compared the LPS-binding functions of MD-1 and MD-2. LPS binding to cell surface complexes was detected for cells transfected with TLR4/MD-2. In contrast, binding was not observed for RP105/MD-1-transfected cells. When rMD-2 protein was expressed in Escherichia coli, it was purified in complexes containing LPS. In contrast, preparations of MD-1 did not contain LPS. When rMD-2 protein was prepared in a mutant strain lacking the lpxM gene, LPS binding disappeared. Therefore, the secondary myristoyl chain attached to the (R)-3-hydroxymyristoyl chain added by LpxM is required for LPS recognition by MD-2, under these conditions. An amphipathic cluster composed of basic and hydrophobic residues in MD-2 has been suggested to be the LPS-binding site. We specifically focused on two Phe residues (119 and 121), which can associate with fatty acids. A mutation at Phe191 or Phe121 strongly reduced binding activity, and a double mutation at these residues prevented any binding from occurring. The Phe residues are present in MD-2 and absent in MD-1. Therefore, the LPS recognition mechanism by RP105/MD-1 is distinct from that of TLR4/MD-2.




This article has been cited by other articles:


Home page
GENES CELLSHome page
S. Ichikawa, T. Takai, T. Yashiki, S. Takahashi, K. Okumura, H. Ogawa, D. Kohda, and H. Hatanaka
Lipopolysaccharide binding of the mite allergen Der f 2
Genes Cells, September 1, 2009; 14(9): 1055 - 1065.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Vasl, P. Prohinar, T. L. Gioannini, J. P. Weiss, and R. Jerala
Functional Activity of MD-2 Polymorphic Variant Is Significantly Different in Soluble and TLR4-Bound Forms: Decreased Endotoxin Binding by G56R MD-2 and Its Rescue by TLR4 Ectodomain
J. Immunol., May 1, 2008; 180(9): 6107 - 6115.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Teghanemt, F. Re, P. Prohinar, R. Widstrom, T. L. Gioannini, and J. P. Weiss
Novel Roles in Human MD-2 of Phenylalanines 121 and 126 and Tyrosine 131 in Activation of Toll-like Receptor 4 by Endotoxin
J. Biol. Chem., January 18, 2008; 283(3): 1257 - 1266.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Divanovic, A. Trompette, L. K. Petiniot, J. L. Allen, L. M. Flick, Y. Belkaid, R. Madan, J. J. Haky, and C. L. Karp
Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105
J. Leukoc. Biol., August 1, 2007; 82(2): 265 - 271.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. M Zimmer, S. M Zughaier, Y.-L. Tzeng, and D. S Stephens
Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4
Glycobiology, August 1, 2007; 17(8): 847 - 856.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M Gorczynski, Y. Kai, and K. Miyake
MD1 Expression Regulates Development of Regulatory T Cells
J. Immunol., July 15, 2006; 177(2): 1078 - 1084.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Kobayashi, S.-i. Saitoh, N. Tanimura, K. Takahashi, K. Kawasaki, M. Nishijima, Y. Fujimoto, K. Fukase, S. Akashi-Takamura, and K. Miyake
Regulatory Roles for MD-2 and TLR4 in Ligand-Induced Receptor Clustering
J. Immunol., May 15, 2006; 176(10): 6211 - 6218.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
J. Koraha, N. Tsuneyoshi, M. Kimoto, J.-F. Gauchat, H. Nakatake, and K. Fukudome
Comparison of Lipopolysaccharide-Binding Functions of CD14 and MD-2
Clin. Vaccine Immunol., November 1, 2005; 12(11): 1292 - 1297.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Teghanemt, D. Zhang, E. N. Levis, J. P. Weiss, and T. L. Gioannini
Molecular Basis of Reduced Potency of Underacylated Endotoxins
J. Immunol., October 1, 2005; 175(7): 4669 - 4676.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Nagai, T. Kobayashi, Y. Motoi, K. Ishiguro, S. Akashi, S.-i. Saitoh, Y. Kusumoto, T. Kaisho, S. Akira, M. Matsumoto, et al.
The Radioprotective 105/MD-1 Complex Links TLR2 and TLR4/MD-2 in Antibody Response to Microbial Membranes
J. Immunol., June 1, 2005; 174(11): 7043 - 7049.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.